Unbiased Analysis of Today's Healthcare Issues
It is not bringing down US prices, but delaying launches in Europe. Reuters reports: Drug launches in EU markets fell by some 35% in the 10 months since Trump’s executive order, compared with the previous 10 months…Delaying launches at lower EU prices could help secure higher U.S. prices for longer. You can read the full…
The Trump administration has introduced three most-favored-nation (MFN) drug pricing initiatives designed to link U.S. pharmaceutical costs to prices paid in economically comparable countries. Most-favored-nation pricing requires manufacturers to provide rebates when U.S. prices exceed those in reference nations—a direct response to the persistent gap between U.S. drug prices and those in other developed economies.…
Last week, CMS announced the GENEROUS (GENErating cost Reductions fOr U.S. Medicaid) Model. The program basically is a ‘most favored nation’ style reference pricing based on net prices from developed countries. The program builds on the Medicaid Drug Rebate Program (MDRP). Specific details specified on the CMS website include: Participating manufacturers whose applications are accepted…
President Trump’s May 12 Executive Order around Most-Favored-Nation drug pricing argues that countries outside the US need to raise their prices on pharmaceuticals saying that many other countries are “freeloading” and paying less than their share for pharmaceuticals. In response, pharmaceutical companies have increased prices in the UK and even threatened to “walk away” from…
The answer seems to be the latter. The Times (UK) reports. Eli Lilly, the US-based manufacturer of Mounjaro, said it was hiking the UK list price for the medication from September 1 to bring it in line with other nations…Eli Lilly is increasing the amount it charges pharmacies. The rate for a middle-sized 5mg dose…
That is the topic from my article out today at The Evidence Base. An excerpt is below: On May 12, 2025, President Trump issued an executive order calling for “most favored nation” (MFN) drug pricing in the US. Key questions you may have include: ▪ What is MFN pricing? ▪ Which countries will be included in…
Perhaps so according to Politico: Trump early next week is expected to sign an executive order directing aides to pursue the initiative, called “most favored nation,” for a selection of drugs within the Medicare program. The idea would use the administration’s authorities to force prices down… White House officials initially pressed congressional Republicans to draft…